Prevalence and real-world management of vedolizumab-associated enthesitis in successfully treated IBD patients.

MLA

Ruscio, Mirko Di, et al. “Prevalence and Real-World Management of Vedolizumab-Associated Enthesitis in Successfully Treated IBD Patients.” Rheumatology, vol. 60, no. 12, Dec. 2021, pp. 5809–13. EBSCOhost, https://doi.org/10.1093/rheumatology/keab135.

APA

Ruscio, M. D., Tinazzi, I., Variola, A., Geccherle, A., Marchetta, A., & McGonagle, D. (2021). Prevalence and real-world management of vedolizumab-associated enthesitis in successfully treated IBD patients. Rheumatology, 60(12), 5809–5813. https://doi.org/10.1093/rheumatology/keab135

Chicago

Ruscio, Mirko Di, Ilaria Tinazzi, Angela Variola, Andrea Geccherle, Antonio Marchetta, and Dennis McGonagle. 2021. “Prevalence and Real-World Management of Vedolizumab-Associated Enthesitis in Successfully Treated IBD Patients.” Rheumatology 60 (12): 5809–13. doi:10.1093/rheumatology/keab135.